2012•China Medical HeraldRequires access

The clinical effect observation of Insulin Aspart 30 for the patients with the newly diagnosed type 2 diabetes

Jia Jingtao

Open publisher page 0 citations

Abstract

Objective To observe the clinical effect of Insulin Aspart 30 for the patients with the newly diagnosed type 2 diabetes.Methods 90 patients with the newly diagnosed type 2 diabetes were divided into the control group(45 cases) and the observation group(45 cases),the FBG,2 h PG and HbA1c after 4 weeks' treatment,the average time for blood glucose,the insulin dosage and the number of cases with low blood sugar were compared.Results After 4 weeks' treatment,the FBG,2 h PG and HbA1c were compared,there were significant differences in the two groups(t = 1.703,1.735,1.784,all P 0.05).The average time for blood glucose,the insulin dosage and the number of cases with low blood sugar were compared,there were significant differences in the two groups(t = 1.713,1.774 and χ2 = 3.873,all P 0.05) in the above aspects,the observation group was better than the control group.Conclusion When the patients with newly type 2 diabetes are treated with Insulin,Insulin Aspart 30 should be used to improve the clinical effect and reduce the incidence of low blood sugar.

About this research paper

What this paper is about

Objective To observe the clinical effect of Insulin Aspart 30 for the patients with the newly diagnosed type 2 diabetes.Methods 90 patients with the newly diagnosed type 2 diabetes were divided into the control group(45 cases) and the observation group(45 cases),the FBG,2 h PG and HbA1c after 4 weeks' treatment,the average time for blood glucose,the insulin dosage and the number of cases with low blood sugar were compared.Results After 4 weeks' treatment,the FBG,2 h PG and HbA1c were compared,there were significant differences in the two groups(t = 1.703,1.735,1.784,all P 0.05).The average time for blood glucose,the insulin dosage and the number of cases with low blood sugar were compared,there were significant differences in the two groups(t = 1.713,1.774 and χ2 = 3.873,all P 0.05) in the above aspects,the observation group was better than the control group.Conclusion When the patients with newly type 2 diabetes are treated with Insulin,Insulin Aspart 30 should be used to improve the clinical effect and reduce the incidence of low blood sugar.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical effect of Insulin Aspart 30 for the patients with the newly diagnosed type 2 diabetes.Methods 90 patients with the newly diagnosed type 2 diabetes were divided into the control group(45 cases) and the observation group(45 cases),the FBG,2 h PG and HbA1c after 4 weeks' treatment,the average time for blood glucose,the insulin dosage and the number of cases with low blood sugar were compared.Results After 4 weeks' treatment,the FBG,2 h PG and HbA1c were compared,there were significant differences in the two groups(t = 1.703,1.735,1.784,all P 0.05).The average time for blood glucose,the insulin dosage and the number of cases with low blood sugar were compared,there were significant differences in the two groups(t = 1.713,1.774 and χ2 = 3.873,all P 0.05) in the above aspects,the observation group was better than the control group.Conclusion When the patients with newly type 2 diabetes are treated with Insulin,Insulin Aspart 30 should be used to improve the clinical effect and reduce the incidence of low blood sugar.

Key concepts: Medicine, Insulin aspart, Insulin, Blood sugar, Diabetes mellitus, Internal medicine, Incidence (geometry), Type 2 diabetes

Related papers

Back to paper searchBrowse research topicsOriginal source
The clinical effect observation of Insulin Aspart 30 for the patients with the newly diagnosed type 2 diabetes — Research Paper | ScholarLens